Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
IsraelRecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Parkinson Disease
Locations
- Cedars-Sinai Department of Neurology, Los Angeles, California, United States
- University of California San Francisco, San Francisco, California, United States
- Parkinson's Disease and Movement Disorders Center, Boca Raton, Florida, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Ichan School of Medicine at Mount Sinai/Beth Israel Downtown-Movement Disorder Center, New York, New York, United States
- Evergreen Health Laboratory, Kirkland, Washington, United States
- Inland Northwest Research, Spokane, Washington, United States
- Technische Universität Dresden, Dresden, Germany
- University of Lübeck, Lübeck, Germany
- University Hospital Tübingen, Tübingen, Germany
- Rabin Medical Center, Petah Tikva, Israel
- Movement Disorders Institute, Sheba Medical Center, Ramat Gan, Israel
- Tel Aviv Medical Center, Tel Aviv, Israel
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Universitari General de Catalunya, Barcelona, Spain
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Hospital Universitario Donostia, Donostia / San Sebastian, Spain
- Universitary Hospital La Princesa, Madrid, Spain
- IDIVAL/University Hospital Marques de Valdecilla, Santander, Spain
- Hospital Universitario Virgen del Rocio, Seville, Spain